nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—DRD2—obesity	0.181	0.564	CbGaD
Lurasidone—HTR2A—obesity	0.14	0.436	CbGaD
Lurasidone—ADRA2C—Methamphetamine—obesity	0.0949	0.242	CbGbCtD
Lurasidone—ADRA2A—Benzphetamine—obesity	0.0783	0.2	CbGbCtD
Lurasidone—ADRA2A—Phenylpropanolamine—obesity	0.0747	0.191	CbGbCtD
Lurasidone—ADRA2A—Methamphetamine—obesity	0.0626	0.16	CbGbCtD
Lurasidone—CYP3A4—Sibutramine—obesity	0.0219	0.0558	CbGbCtD
Lurasidone—CYP3A4—Benzphetamine—obesity	0.0166	0.0423	CbGbCtD
Lurasidone—CYP3A4—Bupropion—obesity	0.0141	0.036	CbGbCtD
Lurasidone—CYP3A4—Orlistat—obesity	0.0115	0.0293	CbGbCtD
Lurasidone—CYP3A4—Cimetidine—obesity	0.0103	0.0264	CbGbCtD
Lurasidone—CYP3A4—Topiramate—obesity	0.00677	0.0173	CbGbCtD
Lurasidone—HTR7—sympathetic nervous system—obesity	0.00431	0.12	CbGeAlD
Lurasidone—HTR7—vagus nerve—obesity	0.00417	0.116	CbGeAlD
Lurasidone—HTR7—autonomic nervous system—obesity	0.0029	0.0805	CbGeAlD
Lurasidone—HTR2A—sympathetic nervous system—obesity	0.00269	0.0747	CbGeAlD
Lurasidone—HTR2A—vagus nerve—obesity	0.0026	0.0724	CbGeAlD
Lurasidone—HTR2A—autonomic nervous system—obesity	0.00181	0.0502	CbGeAlD
Lurasidone—HTR1A—hindbrain—obesity	0.00128	0.0355	CbGeAlD
Lurasidone—HTR7—hindbrain—obesity	0.00122	0.0339	CbGeAlD
Lurasidone—DRD2—hindbrain—obesity	0.00115	0.0321	CbGeAlD
Lurasidone—HTR2A—hindbrain—obesity	0.000761	0.0212	CbGeAlD
Lurasidone—HTR7—respiratory system—obesity	0.000745	0.0207	CbGeAlD
Lurasidone—DRD2—respiratory system—obesity	0.000705	0.0196	CbGeAlD
Lurasidone—Ziprasidone—DRD4—obesity	0.000674	0.195	CrCbGaD
Lurasidone—Ziprasidone—HTR1B—obesity	0.000599	0.174	CrCbGaD
Lurasidone—HTR1A—cardiovascular system—obesity	0.000597	0.0166	CbGeAlD
Lurasidone—ADRA2A—islet of Langerhans—obesity	0.000579	0.0161	CbGeAlD
Lurasidone—ADRA2C—adrenal cortex—obesity	0.000575	0.016	CbGeAlD
Lurasidone—HTR7—cardiovascular system—obesity	0.000571	0.0159	CbGeAlD
Lurasidone—Ziprasidone—DRD1—obesity	0.000571	0.165	CrCbGaD
Lurasidone—Ziprasidone—HTR2C—obesity	0.000488	0.142	CrCbGaD
Lurasidone—DRD2—pituitary gland—obesity	0.000478	0.0133	CbGeAlD
Lurasidone—HTR7—digestive system—obesity	0.000474	0.0132	CbGeAlD
Lurasidone—HTR1A—adrenal gland—obesity	0.000473	0.0131	CbGeAlD
Lurasidone—HTR2A—respiratory system—obesity	0.000465	0.0129	CbGeAlD
Lurasidone—ADRA2C—pituitary gland—obesity	0.000465	0.0129	CbGeAlD
Lurasidone—ADRA2C—adipose tissue—obesity	0.000463	0.0129	CbGeAlD
Lurasidone—HTR7—adrenal gland—obesity	0.000452	0.0126	CbGeAlD
Lurasidone—ADRA2C—adrenal gland—obesity	0.000415	0.0115	CbGeAlD
Lurasidone—HTR1A—endocrine gland—obesity	0.00041	0.0114	CbGeAlD
Lurasidone—Ziprasidone—SLC6A4—obesity	0.000404	0.117	CrCbGaD
Lurasidone—Ziprasidone—DRD2—obesity	0.000402	0.117	CrCbGaD
Lurasidone—HTR7—endocrine gland—obesity	0.000392	0.0109	CbGeAlD
Lurasidone—ADRA2A—pituitary gland—obesity	0.000371	0.0103	CbGeAlD
Lurasidone—DRD2—endocrine gland—obesity	0.00037	0.0103	CbGeAlD
Lurasidone—ADRA2A—adipose tissue—obesity	0.000369	0.0103	CbGeAlD
Lurasidone—HTR2A—cardiovascular system—obesity	0.000356	0.0099	CbGeAlD
Lurasidone—HTR7—liver—obesity	0.000353	0.00981	CbGeAlD
Lurasidone—ADRA2A—adrenal gland—obesity	0.000331	0.00921	CbGeAlD
Lurasidone—ADRA2C—liver—obesity	0.000325	0.00902	CbGeAlD
Lurasidone—HTR2A—pituitary gland—obesity	0.000315	0.00876	CbGeAlD
Lurasidone—Ziprasidone—HTR2A—obesity	0.000311	0.0901	CrCbGaD
Lurasidone—HTR2A—digestive system—obesity	0.000296	0.00822	CbGeAlD
Lurasidone—ADRA2A—endocrine gland—obesity	0.000287	0.00798	CbGeAlD
Lurasidone—HTR2A—adrenal gland—obesity	0.000282	0.00783	CbGeAlD
Lurasidone—CYP3A4—digestive system—obesity	0.000274	0.00761	CbGeAlD
Lurasidone—HTR2A—endocrine gland—obesity	0.000244	0.00679	CbGeAlD
Lurasidone—Influenza—Bupropion—obesity	0.000229	0.00156	CcSEcCtD
Lurasidone—Hepatobiliary disease—Orlistat—obesity	0.000229	0.00156	CcSEcCtD
Lurasidone—Urinary tract infection—Sibutramine—obesity	0.000227	0.00155	CcSEcCtD
Lurasidone—CYP3A4—endocrine gland—obesity	0.000226	0.00628	CbGeAlD
Lurasidone—Salivary hypersecretion—Topiramate—obesity	0.000225	0.00154	CcSEcCtD
Lurasidone—Vomiting—Phenylpropanolamine—obesity	0.000224	0.00153	CcSEcCtD
Lurasidone—Dizziness—Phentermine—obesity	0.000223	0.00152	CcSEcCtD
Lurasidone—Rash—Phenylpropanolamine—obesity	0.000222	0.00152	CcSEcCtD
Lurasidone—Dermatitis—Phenylpropanolamine—obesity	0.000222	0.00152	CcSEcCtD
Lurasidone—HTR2A—liver—obesity	0.00022	0.00612	CbGeAlD
Lurasidone—Abdominal discomfort—Bupropion—obesity	0.000219	0.0015	CcSEcCtD
Lurasidone—Vomiting—Phentermine—obesity	0.000214	0.00147	CcSEcCtD
Lurasidone—Urinary tract disorder—Orlistat—obesity	0.000214	0.00146	CcSEcCtD
Lurasidone—Dysuria—Bupropion—obesity	0.000214	0.00146	CcSEcCtD
Lurasidone—Bradycardia—Sibutramine—obesity	0.000214	0.00146	CcSEcCtD
Lurasidone—Urethral disorder—Orlistat—obesity	0.000213	0.00145	CcSEcCtD
Lurasidone—Rash—Phentermine—obesity	0.000213	0.00145	CcSEcCtD
Lurasidone—Dermatitis—Phentermine—obesity	0.000212	0.00145	CcSEcCtD
Lurasidone—Erectile dysfunction—Bupropion—obesity	0.000211	0.00144	CcSEcCtD
Lurasidone—Nausea—Phenylpropanolamine—obesity	0.000209	0.00143	CcSEcCtD
Lurasidone—Weight increased—Bupropion—obesity	0.000208	0.00142	CcSEcCtD
Lurasidone—Hyperglycaemia—Bupropion—obesity	0.000206	0.00141	CcSEcCtD
Lurasidone—Infestation—Bupropion—obesity	0.000204	0.00139	CcSEcCtD
Lurasidone—Infestation NOS—Bupropion—obesity	0.000204	0.00139	CcSEcCtD
Lurasidone—CYP3A4—liver—obesity	0.000204	0.00567	CbGeAlD
Lurasidone—Diarrhoea—Diethylpropion—obesity	0.000201	0.00137	CcSEcCtD
Lurasidone—Nausea—Phentermine—obesity	0.0002	0.00137	CcSEcCtD
Lurasidone—Asthenia—Cimetidine—obesity	0.0002	0.00137	CcSEcCtD
Lurasidone—Urinary tract infection—Bupropion—obesity	0.000198	0.00136	CcSEcCtD
Lurasidone—Eye disorder—Sibutramine—obesity	0.000196	0.00134	CcSEcCtD
Lurasidone—Sleep disorder—Topiramate—obesity	0.000195	0.00133	CcSEcCtD
Lurasidone—Dizziness—Diethylpropion—obesity	0.000194	0.00133	CcSEcCtD
Lurasidone—Diabetes mellitus—Topiramate—obesity	0.000194	0.00132	CcSEcCtD
Lurasidone—Diarrhoea—Cimetidine—obesity	0.000191	0.00131	CcSEcCtD
Lurasidone—Angiopathy—Sibutramine—obesity	0.00019	0.0013	CcSEcCtD
Lurasidone—Mental disorder—Orlistat—obesity	0.00019	0.0013	CcSEcCtD
Lurasidone—Malnutrition—Orlistat—obesity	0.000189	0.00129	CcSEcCtD
Lurasidone—Arrhythmia—Sibutramine—obesity	0.000188	0.00128	CcSEcCtD
Lurasidone—Vomiting—Diethylpropion—obesity	0.000187	0.00128	CcSEcCtD
Lurasidone—Flatulence—Orlistat—obesity	0.000186	0.00127	CcSEcCtD
Lurasidone—Rash—Diethylpropion—obesity	0.000185	0.00126	CcSEcCtD
Lurasidone—Dermatitis—Diethylpropion—obesity	0.000185	0.00126	CcSEcCtD
Lurasidone—Dizziness—Cimetidine—obesity	0.000185	0.00126	CcSEcCtD
Lurasidone—Malnutrition—Sibutramine—obesity	0.000183	0.00125	CcSEcCtD
Lurasidone—Back pain—Orlistat—obesity	0.000183	0.00125	CcSEcCtD
Lurasidone—Muscle spasms—Orlistat—obesity	0.000182	0.00124	CcSEcCtD
Lurasidone—Urinary tract disorder—Bupropion—obesity	0.000181	0.00124	CcSEcCtD
Lurasidone—Hot flush—Topiramate—obesity	0.00018	0.00123	CcSEcCtD
Lurasidone—Flatulence—Sibutramine—obesity	0.00018	0.00123	CcSEcCtD
Lurasidone—Connective tissue disorder—Bupropion—obesity	0.00018	0.00123	CcSEcCtD
Lurasidone—Urethral disorder—Bupropion—obesity	0.000179	0.00123	CcSEcCtD
Lurasidone—Increased appetite—Topiramate—obesity	0.000179	0.00123	CcSEcCtD
Lurasidone—Menopausal symptoms—Topiramate—obesity	0.000179	0.00122	CcSEcCtD
Lurasidone—Vision blurred—Orlistat—obesity	0.000178	0.00122	CcSEcCtD
Lurasidone—Vomiting—Cimetidine—obesity	0.000177	0.00121	CcSEcCtD
Lurasidone—Back pain—Sibutramine—obesity	0.000177	0.00121	CcSEcCtD
Lurasidone—Rash—Cimetidine—obesity	0.000176	0.0012	CcSEcCtD
Lurasidone—Dermatitis—Cimetidine—obesity	0.000176	0.0012	CcSEcCtD
Lurasidone—Muscle spasms—Sibutramine—obesity	0.000176	0.0012	CcSEcCtD
Lurasidone—Nausea—Diethylpropion—obesity	0.000174	0.00119	CcSEcCtD
Lurasidone—Angioedema—Orlistat—obesity	0.000173	0.00118	CcSEcCtD
Lurasidone—Vision blurred—Sibutramine—obesity	0.000172	0.00118	CcSEcCtD
Lurasidone—Lethargy—Topiramate—obesity	0.000172	0.00118	CcSEcCtD
Lurasidone—Tremor—Sibutramine—obesity	0.000171	0.00117	CcSEcCtD
Lurasidone—Eye disorder—Bupropion—obesity	0.000171	0.00117	CcSEcCtD
Lurasidone—Malaise—Orlistat—obesity	0.00017	0.00116	CcSEcCtD
Lurasidone—Cardiac disorder—Bupropion—obesity	0.00017	0.00116	CcSEcCtD
Lurasidone—Vertigo—Orlistat—obesity	0.00017	0.00116	CcSEcCtD
Lurasidone—Anaemia—Sibutramine—obesity	0.000169	0.00115	CcSEcCtD
Lurasidone—Osteoarthritis—Topiramate—obesity	0.000169	0.00115	CcSEcCtD
Lurasidone—Agitation—Sibutramine—obesity	0.000168	0.00115	CcSEcCtD
Lurasidone—Angioedema—Sibutramine—obesity	0.000167	0.00114	CcSEcCtD
Lurasidone—Angiopathy—Bupropion—obesity	0.000166	0.00114	CcSEcCtD
Lurasidone—Nausea—Cimetidine—obesity	0.000166	0.00113	CcSEcCtD
Lurasidone—Malaise—Sibutramine—obesity	0.000165	0.00113	CcSEcCtD
Lurasidone—Psychotic disorder—Topiramate—obesity	0.000165	0.00113	CcSEcCtD
Lurasidone—Vertigo—Sibutramine—obesity	0.000164	0.00112	CcSEcCtD
Lurasidone—Syncope—Sibutramine—obesity	0.000164	0.00112	CcSEcCtD
Lurasidone—Convulsion—Orlistat—obesity	0.000164	0.00112	CcSEcCtD
Lurasidone—Leukopenia—Sibutramine—obesity	0.000164	0.00112	CcSEcCtD
Lurasidone—Arrhythmia—Bupropion—obesity	0.000163	0.00112	CcSEcCtD
Lurasidone—Myalgia—Orlistat—obesity	0.000161	0.0011	CcSEcCtD
Lurasidone—Loss of consciousness—Sibutramine—obesity	0.000161	0.0011	CcSEcCtD
Lurasidone—Mental disorder—Bupropion—obesity	0.00016	0.0011	CcSEcCtD
Lurasidone—Anxiety—Orlistat—obesity	0.00016	0.0011	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00016	0.00109	CcSEcCtD
Lurasidone—Malnutrition—Bupropion—obesity	0.000159	0.00109	CcSEcCtD
Lurasidone—Convulsion—Sibutramine—obesity	0.000158	0.00108	CcSEcCtD
Lurasidone—Blood creatinine increased—Topiramate—obesity	0.000158	0.00108	CcSEcCtD
Lurasidone—Hypertension—Sibutramine—obesity	0.000158	0.00108	CcSEcCtD
Lurasidone—Dry mouth—Orlistat—obesity	0.000157	0.00108	CcSEcCtD
Lurasidone—Flatulence—Bupropion—obesity	0.000157	0.00107	CcSEcCtD
Lurasidone—Myalgia—Sibutramine—obesity	0.000156	0.00106	CcSEcCtD
Lurasidone—Anxiety—Sibutramine—obesity	0.000155	0.00106	CcSEcCtD
Lurasidone—Back pain—Bupropion—obesity	0.000154	0.00105	CcSEcCtD
Lurasidone—Orthostatic hypotension—Topiramate—obesity	0.000154	0.00105	CcSEcCtD
Lurasidone—Abdominal pain upper—Topiramate—obesity	0.000154	0.00105	CcSEcCtD
Lurasidone—Muscle spasms—Bupropion—obesity	0.000153	0.00105	CcSEcCtD
Lurasidone—Infection—Orlistat—obesity	0.000153	0.00105	CcSEcCtD
Lurasidone—Breast disorder—Topiramate—obesity	0.000152	0.00104	CcSEcCtD
Lurasidone—Dry mouth—Sibutramine—obesity	0.000152	0.00104	CcSEcCtD
Lurasidone—Nervous system disorder—Orlistat—obesity	0.000151	0.00103	CcSEcCtD
Lurasidone—Nasopharyngitis—Topiramate—obesity	0.000151	0.00103	CcSEcCtD
Lurasidone—Vision blurred—Bupropion—obesity	0.00015	0.00103	CcSEcCtD
Lurasidone—Skin disorder—Orlistat—obesity	0.00015	0.00102	CcSEcCtD
Lurasidone—Tremor—Bupropion—obesity	0.000149	0.00102	CcSEcCtD
Lurasidone—Gastritis—Topiramate—obesity	0.000149	0.00102	CcSEcCtD
Lurasidone—Hyperhidrosis—Orlistat—obesity	0.000149	0.00102	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Topiramate—obesity	0.000149	0.00102	CcSEcCtD
Lurasidone—Infection—Sibutramine—obesity	0.000148	0.00101	CcSEcCtD
Lurasidone—Anaemia—Bupropion—obesity	0.000147	0.00101	CcSEcCtD
Lurasidone—Shock—Sibutramine—obesity	0.000147	0.001	CcSEcCtD
Lurasidone—Agitation—Bupropion—obesity	0.000146	0.001	CcSEcCtD
Lurasidone—Dysphagia—Topiramate—obesity	0.000146	0.000996	CcSEcCtD
Lurasidone—Angioedema—Bupropion—obesity	0.000146	0.000995	CcSEcCtD
Lurasidone—Tachycardia—Sibutramine—obesity	0.000146	0.000995	CcSEcCtD
Lurasidone—Skin disorder—Sibutramine—obesity	0.000145	0.000991	CcSEcCtD
Lurasidone—Eosinophilia—Topiramate—obesity	0.000144	0.000986	CcSEcCtD
Lurasidone—Hyperhidrosis—Sibutramine—obesity	0.000144	0.000986	CcSEcCtD
Lurasidone—Malaise—Bupropion—obesity	0.000144	0.000982	CcSEcCtD
Lurasidone—Vertigo—Bupropion—obesity	0.000143	0.000979	CcSEcCtD
Lurasidone—Syncope—Bupropion—obesity	0.000143	0.000977	CcSEcCtD
Lurasidone—Leukopenia—Bupropion—obesity	0.000143	0.000975	CcSEcCtD
Lurasidone—Angina pectoris—Topiramate—obesity	0.000142	0.00097	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Orlistat—obesity	0.00014	0.00096	CcSEcCtD
Lurasidone—Loss of consciousness—Bupropion—obesity	0.00014	0.000957	CcSEcCtD
Lurasidone—Abdominal discomfort—Topiramate—obesity	0.00014	0.000955	CcSEcCtD
Lurasidone—Insomnia—Orlistat—obesity	0.000139	0.000953	CcSEcCtD
Lurasidone—Hypotension—Sibutramine—obesity	0.000139	0.000953	CcSEcCtD
Lurasidone—Convulsion—Bupropion—obesity	0.000138	0.000944	CcSEcCtD
Lurasidone—Hypertension—Bupropion—obesity	0.000138	0.000941	CcSEcCtD
Lurasidone—Neutropenia—Topiramate—obesity	0.000136	0.000931	CcSEcCtD
Lurasidone—Dysuria—Topiramate—obesity	0.000136	0.000931	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Sibutramine—obesity	0.000136	0.000929	CcSEcCtD
Lurasidone—Dyspepsia—Orlistat—obesity	0.000136	0.000928	CcSEcCtD
Lurasidone—Myalgia—Bupropion—obesity	0.000136	0.000927	CcSEcCtD
Lurasidone—Anxiety—Bupropion—obesity	0.000135	0.000924	CcSEcCtD
Lurasidone—Insomnia—Sibutramine—obesity	0.000135	0.000922	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000135	0.000921	CcSEcCtD
Lurasidone—Erectile dysfunction—Topiramate—obesity	0.000134	0.000917	CcSEcCtD
Lurasidone—Decreased appetite—Orlistat—obesity	0.000134	0.000916	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Orlistat—obesity	0.000133	0.00091	CcSEcCtD
Lurasidone—Dyspnoea—Sibutramine—obesity	0.000133	0.000909	CcSEcCtD
Lurasidone—Fatigue—Orlistat—obesity	0.000133	0.000909	CcSEcCtD
Lurasidone—Dry mouth—Bupropion—obesity	0.000133	0.000907	CcSEcCtD
Lurasidone—Somnolence—Sibutramine—obesity	0.000133	0.000907	CcSEcCtD
Lurasidone—Weight increased—Topiramate—obesity	0.000133	0.000907	CcSEcCtD
Lurasidone—Hyperglycaemia—Topiramate—obesity	0.000131	0.000899	CcSEcCtD
Lurasidone—Dyspepsia—Sibutramine—obesity	0.000131	0.000898	CcSEcCtD
Lurasidone—Infestation NOS—Topiramate—obesity	0.00013	0.000888	CcSEcCtD
Lurasidone—Infestation—Topiramate—obesity	0.00013	0.000888	CcSEcCtD
Lurasidone—Decreased appetite—Sibutramine—obesity	0.00013	0.000887	CcSEcCtD
Lurasidone—Infection—Bupropion—obesity	0.000129	0.000883	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Sibutramine—obesity	0.000129	0.00088	CcSEcCtD
Lurasidone—Shock—Bupropion—obesity	0.000128	0.000875	CcSEcCtD
Lurasidone—Renal failure—Topiramate—obesity	0.000128	0.000873	CcSEcCtD
Lurasidone—Nervous system disorder—Bupropion—obesity	0.000127	0.000872	CcSEcCtD
Lurasidone—Tachycardia—Bupropion—obesity	0.000127	0.000868	CcSEcCtD
Lurasidone—Skin disorder—Bupropion—obesity	0.000126	0.000864	CcSEcCtD
Lurasidone—Urinary tract infection—Topiramate—obesity	0.000126	0.000863	CcSEcCtD
Lurasidone—Gastrointestinal pain—Orlistat—obesity	0.000126	0.000862	CcSEcCtD
Lurasidone—Hyperhidrosis—Bupropion—obesity	0.000126	0.000859	CcSEcCtD
Lurasidone—Gastrointestinal pain—Sibutramine—obesity	0.000122	0.000834	CcSEcCtD
Lurasidone—Abdominal pain—Orlistat—obesity	0.000122	0.000833	CcSEcCtD
Lurasidone—Hypotension—Bupropion—obesity	0.000121	0.000831	CcSEcCtD
Lurasidone—Agranulocytosis—Topiramate—obesity	0.000121	0.000829	CcSEcCtD
Lurasidone—Bradycardia—Topiramate—obesity	0.000119	0.000812	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Bupropion—obesity	0.000118	0.00081	CcSEcCtD
Lurasidone—Abdominal pain—Sibutramine—obesity	0.000118	0.000806	CcSEcCtD
Lurasidone—Insomnia—Bupropion—obesity	0.000118	0.000804	CcSEcCtD
Lurasidone—Dyspnoea—Bupropion—obesity	0.000116	0.000793	CcSEcCtD
Lurasidone—Somnolence—Bupropion—obesity	0.000116	0.00079	CcSEcCtD
Lurasidone—Urinary tract disorder—Topiramate—obesity	0.000115	0.000787	CcSEcCtD
Lurasidone—Connective tissue disorder—Topiramate—obesity	0.000115	0.000783	CcSEcCtD
Lurasidone—Dyspepsia—Bupropion—obesity	0.000114	0.000783	CcSEcCtD
Lurasidone—Urethral disorder—Topiramate—obesity	0.000114	0.000782	CcSEcCtD
Lurasidone—Decreased appetite—Bupropion—obesity	0.000113	0.000773	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Bupropion—obesity	0.000112	0.000768	CcSEcCtD
Lurasidone—Fatigue—Bupropion—obesity	0.000112	0.000767	CcSEcCtD
Lurasidone—Asthenia—Orlistat—obesity	0.000111	0.000756	CcSEcCtD
Lurasidone—Pruritus—Orlistat—obesity	0.000109	0.000746	CcSEcCtD
Lurasidone—Eye disorder—Topiramate—obesity	0.000109	0.000745	CcSEcCtD
Lurasidone—Cardiac disorder—Topiramate—obesity	0.000108	0.00074	CcSEcCtD
Lurasidone—Asthenia—Sibutramine—obesity	0.000107	0.000732	CcSEcCtD
Lurasidone—Gastrointestinal pain—Bupropion—obesity	0.000106	0.000727	CcSEcCtD
Lurasidone—Angiopathy—Topiramate—obesity	0.000106	0.000723	CcSEcCtD
Lurasidone—Pruritus—Sibutramine—obesity	0.000106	0.000722	CcSEcCtD
Lurasidone—Diarrhoea—Orlistat—obesity	0.000105	0.000721	CcSEcCtD
Lurasidone—Abdominal pain—Bupropion—obesity	0.000103	0.000703	CcSEcCtD
Lurasidone—Mental disorder—Topiramate—obesity	0.000102	0.000698	CcSEcCtD
Lurasidone—Diarrhoea—Sibutramine—obesity	0.000102	0.000698	CcSEcCtD
Lurasidone—Dizziness—Orlistat—obesity	0.000102	0.000697	CcSEcCtD
Lurasidone—Malnutrition—Topiramate—obesity	0.000101	0.000694	CcSEcCtD
Lurasidone—Flatulence—Topiramate—obesity	0.0001	0.000684	CcSEcCtD
Lurasidone—Dizziness—Sibutramine—obesity	9.86e-05	0.000674	CcSEcCtD
Lurasidone—Back pain—Topiramate—obesity	9.82e-05	0.000671	CcSEcCtD
Lurasidone—Vomiting—Orlistat—obesity	9.8e-05	0.00067	CcSEcCtD
Lurasidone—Muscle spasms—Topiramate—obesity	9.76e-05	0.000667	CcSEcCtD
Lurasidone—Rash—Orlistat—obesity	9.72e-05	0.000664	CcSEcCtD
Lurasidone—Dermatitis—Orlistat—obesity	9.71e-05	0.000664	CcSEcCtD
Lurasidone—Vision blurred—Topiramate—obesity	9.56e-05	0.000654	CcSEcCtD
Lurasidone—Tremor—Topiramate—obesity	9.51e-05	0.00065	CcSEcCtD
Lurasidone—Vomiting—Sibutramine—obesity	9.48e-05	0.000648	CcSEcCtD
Lurasidone—Rash—Sibutramine—obesity	9.4e-05	0.000643	CcSEcCtD
Lurasidone—Dermatitis—Sibutramine—obesity	9.39e-05	0.000642	CcSEcCtD
Lurasidone—Anaemia—Topiramate—obesity	9.38e-05	0.000641	CcSEcCtD
Lurasidone—Asthenia—Bupropion—obesity	9.33e-05	0.000638	CcSEcCtD
Lurasidone—Agitation—Topiramate—obesity	9.33e-05	0.000638	CcSEcCtD
Lurasidone—Pruritus—Bupropion—obesity	9.2e-05	0.000629	CcSEcCtD
Lurasidone—Nausea—Orlistat—obesity	9.15e-05	0.000626	CcSEcCtD
Lurasidone—Malaise—Topiramate—obesity	9.15e-05	0.000626	CcSEcCtD
Lurasidone—Vertigo—Topiramate—obesity	9.12e-05	0.000624	CcSEcCtD
Lurasidone—Syncope—Topiramate—obesity	9.1e-05	0.000622	CcSEcCtD
Lurasidone—Leukopenia—Topiramate—obesity	9.08e-05	0.000621	CcSEcCtD
Lurasidone—Loss of consciousness—Topiramate—obesity	8.92e-05	0.00061	CcSEcCtD
Lurasidone—Diarrhoea—Bupropion—obesity	8.9e-05	0.000608	CcSEcCtD
Lurasidone—Nausea—Sibutramine—obesity	8.86e-05	0.000606	CcSEcCtD
Lurasidone—Convulsion—Topiramate—obesity	8.79e-05	0.000601	CcSEcCtD
Lurasidone—Hypertension—Topiramate—obesity	8.76e-05	0.000599	CcSEcCtD
Lurasidone—Myalgia—Topiramate—obesity	8.64e-05	0.000591	CcSEcCtD
Lurasidone—Anxiety—Topiramate—obesity	8.61e-05	0.000589	CcSEcCtD
Lurasidone—Dizziness—Bupropion—obesity	8.6e-05	0.000588	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	8.58e-05	0.000587	CcSEcCtD
Lurasidone—Dry mouth—Topiramate—obesity	8.45e-05	0.000578	CcSEcCtD
Lurasidone—Vomiting—Bupropion—obesity	8.27e-05	0.000565	CcSEcCtD
Lurasidone—Infection—Topiramate—obesity	8.23e-05	0.000563	CcSEcCtD
Lurasidone—Rash—Bupropion—obesity	8.2e-05	0.000561	CcSEcCtD
Lurasidone—Dermatitis—Bupropion—obesity	8.19e-05	0.00056	CcSEcCtD
Lurasidone—Shock—Topiramate—obesity	8.15e-05	0.000557	CcSEcCtD
Lurasidone—Nervous system disorder—Topiramate—obesity	8.12e-05	0.000555	CcSEcCtD
Lurasidone—Tachycardia—Topiramate—obesity	8.08e-05	0.000553	CcSEcCtD
Lurasidone—Skin disorder—Topiramate—obesity	8.05e-05	0.00055	CcSEcCtD
Lurasidone—Hyperhidrosis—Topiramate—obesity	8.01e-05	0.000548	CcSEcCtD
Lurasidone—Hypotension—Topiramate—obesity	7.74e-05	0.000529	CcSEcCtD
Lurasidone—Nausea—Bupropion—obesity	7.72e-05	0.000528	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Topiramate—obesity	7.55e-05	0.000516	CcSEcCtD
Lurasidone—Insomnia—Topiramate—obesity	7.49e-05	0.000512	CcSEcCtD
Lurasidone—Dyspnoea—Topiramate—obesity	7.38e-05	0.000505	CcSEcCtD
Lurasidone—Somnolence—Topiramate—obesity	7.36e-05	0.000504	CcSEcCtD
Lurasidone—Dyspepsia—Topiramate—obesity	7.29e-05	0.000499	CcSEcCtD
Lurasidone—Decreased appetite—Topiramate—obesity	7.2e-05	0.000492	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Topiramate—obesity	7.15e-05	0.000489	CcSEcCtD
Lurasidone—Fatigue—Topiramate—obesity	7.14e-05	0.000488	CcSEcCtD
Lurasidone—Gastrointestinal pain—Topiramate—obesity	6.77e-05	0.000463	CcSEcCtD
Lurasidone—Abdominal pain—Topiramate—obesity	6.55e-05	0.000448	CcSEcCtD
Lurasidone—Asthenia—Topiramate—obesity	5.94e-05	0.000406	CcSEcCtD
Lurasidone—Pruritus—Topiramate—obesity	5.86e-05	0.000401	CcSEcCtD
Lurasidone—Diarrhoea—Topiramate—obesity	5.67e-05	0.000388	CcSEcCtD
Lurasidone—Dizziness—Topiramate—obesity	5.48e-05	0.000375	CcSEcCtD
Lurasidone—Vomiting—Topiramate—obesity	5.27e-05	0.00036	CcSEcCtD
Lurasidone—Rash—Topiramate—obesity	5.22e-05	0.000357	CcSEcCtD
Lurasidone—Dermatitis—Topiramate—obesity	5.22e-05	0.000357	CcSEcCtD
Lurasidone—Nausea—Topiramate—obesity	4.92e-05	0.000336	CcSEcCtD
Lurasidone—DRD2—Signaling Pathways—LEP—obesity	3.52e-06	3.44e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—APOE—obesity	3.52e-06	3.44e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PIK3CG—obesity	3.5e-06	3.43e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CAV1—obesity	3.49e-06	3.41e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—APOA1—obesity	3.48e-06	3.41e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—NOS3—obesity	3.48e-06	3.4e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PIK3R1—obesity	3.48e-06	3.4e-05	CbGpPWpGaD
Lurasidone—HTR7—GPCR downstream signaling—AKT1—obesity	3.48e-06	3.4e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—DPYD—obesity	3.47e-06	3.39e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—LEP—obesity	3.47e-06	3.39e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—APOE—obesity	3.47e-06	3.39e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PRKCD—obesity	3.47e-06	3.39e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IRS1—obesity	3.46e-06	3.39e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—POMC—obesity	3.45e-06	3.37e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CAV1—obesity	3.43e-06	3.36e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—INS—obesity	3.43e-06	3.35e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—APOA1—obesity	3.43e-06	3.35e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—IL6—obesity	3.42e-06	3.35e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PIK3CG—obesity	3.4e-06	3.33e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—HTR2A—obesity	3.39e-06	3.32e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—C3—obesity	3.39e-06	3.31e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—CCL2—obesity	3.37e-06	3.3e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—ESR1—obesity	3.36e-06	3.29e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PRKAR2B—obesity	3.34e-06	3.26e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—POMC—obesity	3.34e-06	3.26e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—F2—obesity	3.32e-06	3.25e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PRKCB—obesity	3.32e-06	3.25e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—INS—obesity	3.32e-06	3.24e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IGF1—obesity	3.32e-06	3.24e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—DCN—obesity	3.31e-06	3.24e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AKT2—obesity	3.31e-06	3.24e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—ESR1—obesity	3.31e-06	3.24e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PPARG—obesity	3.28e-06	3.21e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—BAD—obesity	3.28e-06	3.21e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PRKCB—obesity	3.27e-06	3.2e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—F2—obesity	3.27e-06	3.2e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—CCL2—obesity	3.26e-06	3.19e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MMP9—obesity	3.25e-06	3.18e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—POMC—obesity	3.24e-06	3.17e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—BAD—obesity	3.23e-06	3.16e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CPT1A—obesity	3.22e-06	3.15e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IRS2—obesity	3.22e-06	3.15e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—INS—obesity	3.22e-06	3.15e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AGT—obesity	3.22e-06	3.15e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PIK3CB—obesity	3.21e-06	3.14e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IGF1—obesity	3.21e-06	3.14e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AKT2—obesity	3.21e-06	3.13e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Hemostasis—AKT1—obesity	3.2e-06	3.13e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PIK3CD—obesity	3.18e-06	3.11e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PTGS2—obesity	3.18e-06	3.11e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PIK3CG—obesity	3.18e-06	3.11e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MAPK8—obesity	3.16e-06	3.1e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NAMPT—obesity	3.16e-06	3.09e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling by GPCR—AKT1—obesity	3.16e-06	3.09e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APOE—obesity	3.15e-06	3.08e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—LEP—obesity	3.15e-06	3.08e-05	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—PIK3CA—obesity	3.15e-06	3.08e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—SERPINE1—obesity	3.15e-06	3.08e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IRS1—obesity	3.14e-06	3.07e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—LIPC—obesity	3.14e-06	3.07e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GCK—obesity	3.14e-06	3.07e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PIK3CG—obesity	3.13e-06	3.06e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CAV1—obesity	3.12e-06	3.06e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOC3—obesity	3.12e-06	3.05e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—APOA1—obesity	3.12e-06	3.05e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IRS1—obesity	3.09e-06	3.02e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PIK3CD—obesity	3.08e-06	3.01e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TYK2—obesity	3.06e-06	2.99e-05	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—PIK3CA—obesity	3.05e-06	2.98e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—SERPINE1—obesity	3.05e-06	2.98e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—RHOA—obesity	3.04e-06	2.97e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CETP—obesity	3.03e-06	2.96e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—POMC—obesity	3.03e-06	2.96e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—ESR1—obesity	3.01e-06	2.94e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—INS—obesity	3.01e-06	2.94e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PIK3R1—obesity	3.01e-06	2.94e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—NOS3—obesity	3.01e-06	2.94e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SDC1—obesity	3e-06	2.93e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PIK3CD—obesity	2.99e-06	2.93e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—POMC—obesity	2.98e-06	2.91e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—F2—obesity	2.97e-06	2.91e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PRKCB—obesity	2.97e-06	2.91e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TYK2—obesity	2.96e-06	2.9e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—INS—obesity	2.96e-06	2.9e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—CCL2—obesity	2.96e-06	2.9e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—ALB—obesity	2.95e-06	2.89e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AKR1C3—obesity	2.95e-06	2.88e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—RHOA—obesity	2.94e-06	2.87e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—BAD—obesity	2.94e-06	2.87e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—CCL2—obesity	2.91e-06	2.85e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IGF1—obesity	2.91e-06	2.85e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AKT2—obesity	2.91e-06	2.84e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—NOS3—obesity	2.91e-06	2.84e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PIK3R1—obesity	2.91e-06	2.84e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SCARB1—obesity	2.9e-06	2.84e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—STAT3—obesity	2.89e-06	2.83e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IGF1—obesity	2.86e-06	2.8e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—PIK3CA—obesity	2.86e-06	2.8e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AKT2—obesity	2.86e-06	2.8e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PIK3CG—obesity	2.85e-06	2.78e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—NOS3—obesity	2.83e-06	2.76e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PIK3R1—obesity	2.83e-06	2.76e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SREBF1—obesity	2.82e-06	2.76e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IRS1—obesity	2.81e-06	2.75e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PIK3CD—obesity	2.79e-06	2.73e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PIK3CB—obesity	2.77e-06	2.71e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MTOR—obesity	2.77e-06	2.71e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—PIK3CA—obesity	2.77e-06	2.71e-05	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—PIK3CA—obesity	2.77e-06	2.71e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—SERPINE1—obesity	2.76e-06	2.7e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PIK3CD—obesity	2.75e-06	2.69e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GOT2—obesity	2.74e-06	2.68e-05	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—PIK3CA—obesity	2.72e-06	2.66e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—SERPINE1—obesity	2.72e-06	2.66e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—POMC—obesity	2.71e-06	2.65e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—INS—obesity	2.69e-06	2.63e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—MYC—obesity	2.69e-06	2.63e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TYK2—obesity	2.69e-06	2.63e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MTOR—obesity	2.68e-06	2.63e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PIK3CB—obesity	2.68e-06	2.63e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—TGFB1—obesity	2.68e-06	2.62e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—FASN—obesity	2.68e-06	2.62e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—BCHE—obesity	2.67e-06	2.61e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—RHOA—obesity	2.67e-06	2.61e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—CCL2—obesity	2.65e-06	2.59e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TYK2—obesity	2.65e-06	2.59e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—NOS3—obesity	2.64e-06	2.58e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PIK3R1—obesity	2.64e-06	2.58e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—RHOA—obesity	2.62e-06	2.57e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PIK3CB—obesity	2.61e-06	2.55e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IGF1—obesity	2.61e-06	2.55e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AKT2—obesity	2.6e-06	2.55e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—NOS3—obesity	2.6e-06	2.54e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PIK3R1—obesity	2.6e-06	2.54e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PTGS2—obesity	2.58e-06	2.53e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP2E1—obesity	2.58e-06	2.52e-05	CbGpPWpGaD
Lurasidone—HTR1A—GPCR downstream signaling—AKT1—obesity	2.58e-06	2.52e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NQO1—obesity	2.55e-06	2.49e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—IL6—obesity	2.54e-06	2.48e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—PIK3CA—obesity	2.51e-06	2.46e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PIK3CD—obesity	2.5e-06	2.45e-05	CbGpPWpGaD
Lurasidone—ADRA2C—GPCR downstream signaling—AKT1—obesity	2.49e-06	2.44e-05	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	2.48e-06	2.42e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—SERPINE1—obesity	2.47e-06	2.42e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—PIK3CA—obesity	2.47e-06	2.42e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—IL6—obesity	2.45e-06	2.4e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—SLC2A4—obesity	2.44e-06	2.39e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GCG—obesity	2.44e-06	2.39e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MTOR—obesity	2.44e-06	2.38e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PIK3CB—obesity	2.44e-06	2.38e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MMP9—obesity	2.41e-06	2.36e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYCS—obesity	2.41e-06	2.36e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TYK2—obesity	2.41e-06	2.35e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MTOR—obesity	2.4e-06	2.34e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PIK3CB—obesity	2.4e-06	2.34e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—RHOA—obesity	2.39e-06	2.33e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GOT1—obesity	2.37e-06	2.31e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GGT1—obesity	2.37e-06	2.31e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—NOS3—obesity	2.36e-06	2.31e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PIK3R1—obesity	2.36e-06	2.31e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MAPK8—obesity	2.35e-06	2.29e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling by GPCR—AKT1—obesity	2.34e-06	2.29e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MMP9—obesity	2.33e-06	2.28e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NCOA1—obesity	2.33e-06	2.28e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—STK11—obesity	2.3e-06	2.25e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CYP19A1—obesity	2.3e-06	2.25e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—PIK3CA—obesity	2.28e-06	2.23e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MAPK8—obesity	2.27e-06	2.22e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling by GPCR—AKT1—obesity	2.26e-06	2.21e-05	CbGpPWpGaD
Lurasidone—DRD2—GPCR downstream signaling—AKT1—obesity	2.26e-06	2.21e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—PIK3CA—obesity	2.25e-06	2.2e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—IL6—obesity	2.23e-06	2.18e-05	CbGpPWpGaD
Lurasidone—HTR2A—GPCR downstream signaling—AKT1—obesity	2.23e-06	2.18e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—IL6—obesity	2.19e-06	2.14e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MTOR—obesity	2.18e-06	2.13e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PIK3CB—obesity	2.18e-06	2.13e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—STAT3—obesity	2.14e-06	2.1e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—COMT—obesity	2.14e-06	2.09e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MMP9—obesity	2.12e-06	2.07e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GNB3—obesity	2.11e-06	2.06e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARGC1A—obesity	2.11e-06	2.06e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—HMOX1—obesity	2.1e-06	2.05e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MMP9—obesity	2.08e-06	2.04e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—STAT3—obesity	2.07e-06	2.03e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MAPK8—obesity	2.06e-06	2.01e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling by GPCR—AKT1—obesity	2.05e-06	2.01e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GNAS—obesity	2.05e-06	2e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MAPK8—obesity	2.03e-06	1.98e-05	CbGpPWpGaD
Lurasidone—ADRA2A—GPCR downstream signaling—AKT1—obesity	2.02e-06	1.98e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—IL6—obesity	2.02e-06	1.98e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling by GPCR—AKT1—obesity	2.02e-06	1.98e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOB—obesity	2.01e-06	1.96e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—IL6—obesity	1.99e-06	1.95e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—MYC—obesity	1.99e-06	1.95e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—TGFB1—obesity	1.99e-06	1.94e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—PIK3CA—obesity	1.96e-06	1.91e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—MYC—obesity	1.93e-06	1.89e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—TGFB1—obesity	1.92e-06	1.88e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—LPL—obesity	1.92e-06	1.87e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MMP9—obesity	1.9e-06	1.85e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—STAT3—obesity	1.88e-06	1.84e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—GPX1—obesity	1.87e-06	1.83e-05	CbGpPWpGaD
Lurasidone—HTR7—Signaling Pathways—AKT1—obesity	1.86e-06	1.82e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—STAT3—obesity	1.85e-06	1.81e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MAPK8—obesity	1.84e-06	1.8e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling by GPCR—AKT1—obesity	1.84e-06	1.8e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CD36—obesity	1.82e-06	1.78e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—MYC—obesity	1.75e-06	1.71e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—TGFB1—obesity	1.75e-06	1.71e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—MTHFR—obesity	1.73e-06	1.69e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—MYC—obesity	1.72e-06	1.68e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—TGFB1—obesity	1.72e-06	1.68e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARA—obesity	1.69e-06	1.66e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—PIK3CA—obesity	1.69e-06	1.65e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—STAT3—obesity	1.69e-06	1.65e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AGT—obesity	1.64e-06	1.6e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—PIK3CA—obesity	1.64e-06	1.6e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOE—obesity	1.61e-06	1.57e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Metabolism—AKT1—obesity	1.6e-06	1.56e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—CAV1—obesity	1.59e-06	1.56e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—PIK3CA—obesity	1.59e-06	1.55e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—APOA1—obesity	1.59e-06	1.55e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—MYC—obesity	1.57e-06	1.53e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—TGFB1—obesity	1.56e-06	1.53e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—IL6—obesity	1.5e-06	1.46e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—PIK3CA—obesity	1.49e-06	1.45e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—PIK3CA—obesity	1.46e-06	1.43e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PIK3CG—obesity	1.45e-06	1.42e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—IL6—obesity	1.45e-06	1.42e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PPARG—obesity	1.4e-06	1.37e-05	CbGpPWpGaD
Lurasidone—HTR1A—Signaling Pathways—AKT1—obesity	1.38e-06	1.35e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—POMC—obesity	1.38e-06	1.35e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—INS—obesity	1.37e-06	1.34e-05	CbGpPWpGaD
Lurasidone—ADRA2C—Signaling Pathways—AKT1—obesity	1.34e-06	1.31e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—PIK3CA—obesity	1.33e-06	1.3e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—IL6—obesity	1.31e-06	1.29e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Metabolism—AKT1—obesity	1.3e-06	1.27e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—IL6—obesity	1.29e-06	1.27e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PIK3CD—obesity	1.27e-06	1.25e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—ALB—obesity	1.26e-06	1.23e-05	CbGpPWpGaD
Lurasidone—DRD2—Signaling Pathways—AKT1—obesity	1.21e-06	1.19e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PIK3R1—obesity	1.2e-06	1.18e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—NOS3—obesity	1.2e-06	1.18e-05	CbGpPWpGaD
Lurasidone—HTR2A—Signaling Pathways—AKT1—obesity	1.19e-06	1.17e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—IL6—obesity	1.18e-06	1.15e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PIK3CB—obesity	1.11e-06	1.09e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PTGS2—obesity	1.1e-06	1.08e-05	CbGpPWpGaD
Lurasidone—ADRA2A—Signaling Pathways—AKT1—obesity	1.09e-06	1.06e-05	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—PIK3CA—obesity	6.77e-07	6.62e-06	CbGpPWpGaD
Lurasidone—CYP3A4—Metabolism—AKT1—obesity	5.53e-07	5.41e-06	CbGpPWpGaD
